Reuters logo
BRIEF-Panion & BF Biotech signs license and exclusive distribution agreement with Kyowa Hakko Kirin Korea
February 20, 2017 / 5:30 AM / 9 months ago

BRIEF-Panion & BF Biotech signs license and exclusive distribution agreement with Kyowa Hakko Kirin Korea

Feb 20 (Reuters) - Panion & BF Biotech Inc:

* Says it signed a license and exclusive distribution agreement with Kyowa Hakko Kirin Korea Co Ltd

* Says the two companies will cooperate on development of Korea market for its new kidney disease durg named Nephoxil

Source text in Chinese: goo.gl/tQo9jM

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below